<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778452</url>
  </required_header>
  <id_info>
    <org_study_id>VLC18012013</org_study_id>
    <nct_id>NCT01778452</nct_id>
  </id_info>
  <brief_title>Endometrial Genomic Profile in Endometrial Priming</brief_title>
  <official_title>Profile Study of Genomics Endometrial Expression After Gonadotropin-releasing Hormone Agonist Administration and GnRH in Endometrial Priming.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Igenomix</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyse genomics profile expression in endometrium under
      different endometrial priming for recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We analyze the genomic profile of egg donors in different endometrial priming protocols,
      compared with natural cycle, including the conventional single long acting GnRH agonist
      injection in the mid luteal phase of the previous cycle of the endometrial priming and the
      single daily antagonist injection (Cetrorelix 0.25 mg) administered in the early follicular
      phase followed by endometrial priming. Endometrial biopsy will be taken in luteinizing
      hormone

        -  7 or with P4 +5 in cases with endometrial priming with oestrogens therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>genetic endometrial human profile expression</measure>
    <time_frame>Oocyte donors will be followed up for four to six months</time_frame>
    <description>implantation related genes profile expression</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Genomic Human Endometrial Expression Profile</condition>
  <arm_group>
    <arm_group_label>Natural cycle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Natural cycle endometrial biopsy, lh+7</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antagonist cycle + endometrial priming.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Antagonist cycle + endometrial priming for egg donation program. endometrial biopsy, p4+5</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Agonist cycle + endometrial priming.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Agonist cycle + endometrial priming for egg donation program endometrial biopsy, p4+5</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endometrial biopsy</intervention_name>
    <description>endometrial biopsy</description>
    <arm_group_label>Natural cycle</arm_group_label>
    <arm_group_label>Antagonist cycle + endometrial priming.</arm_group_label>
    <arm_group_label>Agonist cycle + endometrial priming.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6 egg healthy volunteer egg donors.

          -  Volunteers.

          -  18-35 years old

          -  Healthy.

          -  BMI &lt;28.

        Exclusion Criteria:

          -  - BMI &gt; 28

          -  Smokers-
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen Vidal, MDphD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Valencia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ivi Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>February 14, 2013</last_update_submitted>
  <last_update_submitted_qc>February 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

